Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Total Stockholders Equity : HK$2,563.6 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Total Stockholders Equity?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was HK$2,563.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was HK$2.46. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Total Stockholders Equity Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,036.56

2,383.82

2,685.19

2,520.54

2,578.64

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															-	2,536.36	2,505.49	2,578.64	2,563.60

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2563.598	-	0)	/	1043
	=	2.46

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	10.722)	/	2563.598
	=	0.00

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

688505:China

Address

No. 308, Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210

Website

http://www.fd-zj.com

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Headlines

No Headlines